Men’s Health – What You Should Know 

Posted by Brigham and Women's Hospital June 7, 2016

June is Men’s Health Month, a time to address important health issues that impact men’s lives. Read the stories below to learn the latest about prostate cancer, testosterone therapy, erectile dysfunction, and other factors that affect men’s physical and mental health.

Healthy-Men-1Hormone Therapy for Prostate Cancer May Increase Risk of Depression

A Brigham and Women’s Hospital (BWH) study has found a significant association between depression and patients being treated for localized prostate cancer with androgen deprivation therapy (ADT). When compared to patients who did not receive ADT, patients who received ADT had higher incidences of depression and inpatient and outpatient psychiatric treatment.

 

Healthy-Men-2Testosterone’s Effect on the Heart and Quality of Life

Testosterone use among men doesn’t appear to increase their risk of developing atherosclerosis (hardening of the arteries), a critical risk factor for heart attack and stroke. However, research also shows that men using testosterone fail to realize the quality of life benefits that are often the primary goals of testosterone therapy.

 

Healthy-Men-3Treatment Options for Erectile Dysfunction

Age, high blood pressure, and cardiovascular disease contribute to a higher risk of erectile dysfunction (ED), which affects about one half of American men over age 40 at some point in their lives. Most men experiencing ED respond to nonsurgical treatments, such as oral medications or self-injection therapy. However, if these treatments don’t work, surgery may provide another option.

 

Healthy-Men-4Breakfast Makes a Man’s Heart Healthy

Research shows that men who skip breakfast have a 27 percent higher risk of suffering a heart attack or developing heart disease than those who start the day with something in their stomach. These men who forego breakfast also indulge more heavily in other unhealthy lifestyle choices, such as smoking, exercising less, and drinking alcohol regularly.

 

Healthy-Men-5Prostate Cancer Screening – Who Recommends PSA Testing?

BWH-led research finds that a patient’s likelihood of getting prostate-specific antigen (PSA) testing for the early detection of prostate cancer depends on the type of physician he sees. According to the study’s lead author, the findings highlight the need for physicians to reach a broader consensus on the risks and benefits of prostate cancer screening and the importance of patients discussing their care options with their physicians.

Prostate Cancer Screening – Who Recommends PSA Testing?

Posted by Brigham and Women's Hospital March 17, 2016

prostate-specific antigen (PSA) testing for the early detection of prostate cancer may depend on the type of physician a patient sees.

The likelihood of a patient getting a PSA test for the early detection of prostate cancer may depend on the type of physician he sees.

Dr. Quoc-Dien Trinh is a urologist at Brigham and Women’s Hospital (BWH).

Recent research led by Brigham and Women’s Hospital suggests that the likelihood of a patient getting prostate-specific antigen (PSA) testing for the early detection of prostate cancer depends on the type of physician he sees.

In October 2011, the U.S. Preventive Services Task Force (USPSTF) issued a recommendation against the use of PSA testing for prostate cancer screening for all men. In its assessment, the task force concluded that, overall, the harms of PSA testing outweigh its benefits. The study authors, however, hypothesized that adoption of the USPSTF recommendation would vary according to a physician’s specialty.

The researchers examined PSA testing use among primary care physicians (PCPs) and urologists in the year immediately before the recommendation was issued and the year immediately afterward. To focus on preventive care visits, men previously diagnosed with prostate cancer, an elevated PSA level, or other prostate conditions were excluded from the study.

The study found that PSA testing for men aged 50-74 years decreased significantly from 36.5 percent in 2010 to 16.4 percent in 2012 among PCPs. However, during those same years, such testing among urologists only decreased from 38.7 percent to 34.5 percent.

Read More »